Amide Derivative Solid Dispersion for Solubility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing amide derivatives, such as compound A, have low solubility and chemical stability, making it difficult to formulate effective pharmaceutical compositions for treating herpesvirus-related diseases, especially when large doses are required, and existing methods like salt formation and clathrate inclusion do not adequately improve solubility or stability.
Innovation Solution
A solid dispersion is created by dissolving or suspending the amide derivative with a water-soluble polymer like hydroxypropylmethyl cellulose or copolyvidone in a pharmaceutically acceptable solvent and then removing the solvent through spray drying, enhancing solubility and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If the amide derivative is used in large doses to achieve therapeutic effect, then the therapeutic efficacy is improved, but the formulation size increases and solubility problems worsen
Solution Approach 1:
The patent changes the physical state of the amide derivative from crystalline to amorphous form through solid dispersion technology. This parameter change in molecular arrangement allows significantly higher drug loading concentration in the formulation, enabling large doses to be delivered in a compact volume while maintaining or improving solubility.
Solution Approach 2:
The patent creates a composite material system by combining the amide derivative with specific carriers or excipients in a solid dispersion matrix. This composite approach allows the drug to be dispersed at high concentrations without crystallizing, thereby achieving both large dose capacity and small formulation size simultaneously.
2Quantity of substance
If conventional solubility improvement methods like salt formation are used, then solubility is improved, but chemical stability deteriorates due to heat decomposition
Solution Approach 1:
The patent utilizes the phase transition from crystalline to amorphous state of the amide derivative. The amorphous phase provides enhanced solubility without requiring salt formation, and crucially, this phase state is achieved through physical mixing in solid dispersion rather than chemical modification, thereby preserving chemical stability and avoiding heat-induced decomposition.
Solution Approach 2:
The patent introduces carriers or excipients as intermediary substances that facilitate the amorphous dispersion of the amide derivative. These intermediaries stabilize the amorphous phase and provide the solubility enhancement effect without requiring the amide derivative to undergo chemical changes that would compromise its stability.
3Quantity of substance
If the amide derivative is formulated as solid dispersion to improve solubility, then solubility and absorption are improved, but manufacturing complexity increases
Solution Approach 1:
The patent employs self-service principles by selecting carriers and processing conditions that enable the amide derivative to form solid dispersion automatically during conventional tablet manufacturing processes. The formulation system self-organizes into the desired amorphous dispersion state without requiring additional specialized equipment or complex processing steps beyond standard capsule filling or tablet compression.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly improves the solubility and oral absorption of the amide derivative, allows for a more compact and stable pharmaceutical formulation with improved compression moldability, and maintains stability against heat, reducing degradation products to safe levels.
Implementation Method 1
a solid dispersion containing an amide derivative useful in preventing and treating diseases in which herpesviruses are involved and a water-soluble polymer
Implementation Method 2
dissolving or suspending the amide derivative with a water-soluble polymer like hydroxypropylmethyl cellulose or copolyvidone in a pharmaceutically acceptable solvent and then removing the solvent through spray drying
Data Source
Figure 1~3
Figure 4~6
AI summary
The present invention relates to a pharmaceutical composition containing a solid dispersion comprising an amide derivative or a salt thereof and a water-soluble polymer, wherein the pharmaceutical composition is not prepared by a melting method. The pharmaceutical composition contains the solid dispersion having an improved oral absorption, properties suitable for formulation, and an excellent stability.